Primer: Global Health (Medanta) (MEDANTA IN) - Apr 2026
Strong Financial Growth and Expansion: Global Health (Medanta) has demonstrated a robust financial track record with significant year-over-year...
139 Views
Global Health Ltd - Strengthening Network with Noida Launch
Steady Q2FY26 Performance: Medanta delivered a broadly in-line performance in Q2FY26, with revenue of Rs 1,099 Cr, up 15% YoY and 6.6% QoQ.
148 Views
APAC Healthcare Weekly (July 26) – Hengrui, BeOne, Takeda, Nippon Shinyaku, Samsung Bio, Celltrion
Hengrui’s camrelizumab got indication expansion approval for cervical cancer. BeOne announced $300M expansion plan for US facility. Samsung...
132 Views
India’s Cancer Care Opportunity: Listed Proxies for a 1.6 Million-Case Market
​India faces a growing cancer burden with 1.56 million new cases in 2024, highlighting the need for increased oncology capacity and accessible...
117 Views
APAC Healthcare Weekly (March 29) – Hansoh, CSPC, Chugai, Takeda, Otsuka, Celltrion, Alteogen
Hansoh got trial approval, while CSPC obtained new drug approval. Chugai’s partner is discontinuing development of emugrobart. Otsuka is acquiring...
336 Views